Obsessive-Compulsive Disorder Clinical Trials

Harmonex Neuroscience Research
Dothan Alabama 36303

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

UCLA Semel institute
Los Angeles California 90024

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Oceanside California 92056

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

Stanford California 94305-2200

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

Institute of Living/Hartford Hospital
Hartford Connecticut 06106

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

University of Florida
Gainesville Florida 32610

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Nemours Children's Clinic, Dept. of Psychology and Psychiatry
Jacksonville Florida 32207

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Medical Research Group of Central Florida
Orange City Florida 32763

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Harmonex Neuroscience of Pensacola
Pensacola Florida 32502

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

University of South Florida - Rothman Center
St. Petersburg Florida 33701

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Family Behavioral Health
Plainfield Illinois 60585

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Family Service and Guidance Center
Topeka Kansas 66606

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical research study of Duloxetine for the treatment of Obsessive Compulsive Disorder

Massachusetts General Hospital
Boston Massachusetts 02114

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

Baystate Medical Center, Child Behavioral Health Research
Springfield Massachusetts 01199

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Minneapolis Minnesota 55454

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

Mayo Clinic
Rochester Minnesota 55905

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Saint John's Clinic
Springfield Missouri 65804

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

St. Louis Missouri 63118

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

Mount Sinai School of Medicine
New York New York 10029

A clinical trial to evaluate treatments using topiramate for patients with Obsessive-Compulsive Disorder

New York New York 10029

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

3-C Family Services, P.A.
Cary North Carolina 27513

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Duke University Medical Center, Division of Child & Adolescent Psychiatry
Durham North Carolina 27705

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Private Practice
Wilmington North Carolina 28401

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Family Center by the Falls
Chagrin Falls Ohio 44023

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Cincinnati Childrens Hospital and Medical Center
Cincinnati Ohio 45220

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

W.O. Walker Building
Cleveland Ohio 44106

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Providence Rhode Island 02906

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

Memphis Tennessee 38119

Patients are needed to participate in a clinical research study of bitopertin and placebo to evaluate Obsessive-Compulsive Disorder

University of Texas Southwestern Medical Center at Dallas
Dallas Texas 75235

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Bay Pointe Behavioral Health Service, Inc.
Friendswood Texas 77546

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

Midtown Psychiatry and TMS Center
Houston Texas 77007

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

University of Virginia Health System
Charlottesville Virginia 22903

A Phase 4 clinical study for patients with Obsessive Compulsive Disorder

MacAnxiety Research Centre
Hamilton Ontario L8S 1B7

A clinical research study of pregabalin and Placebo for the treatment of Obsessive-Compulsive Disorder

MacAnxiety Research Centre
Hamilton Ontario L8S 1B7

A Phase 4 clinical study for patients using Sertraline and Placebo

MacAnxiety Research Centre
Hamilton Ontario L8S 1B7

Patients are needed to participate in a clinical research study of Topiramate and placebo to evaluate Obsessive Compulsive Disorder

University of Ottawa Institute of Mental Health Research
Ottawa Ontario K1Z7K4

Patients are needed to participate in a clinical research study of Escitalopram to evaluate Obsessive Compulsive Disorder

Sheba Medical Center
Ramat Gan

Patients are needed to participate in a clinical research study evaluating Deep TMS for the treatment of Obsessive Compulsive Disorder

Department of Psychiatry Chaim Sheba Medical Center
Tel Hashomer

A clinical trial to evaluate treatments using Agomelatine A and Placebo for patients with Obsessive Compulsive Disorder

Site Reference ID/Investigator# 105820
Hokkaido

A clinical research study of fluvoxamine maleate and placebo for the treatment of Obsessive Compulsive Disorder

Site Reference ID/Investigator# 105818
Hyogo

A clinical research study of fluvoxamine maleate and placebo for the treatment of Obsessive Compulsive Disorder

Site Reference ID/Investigator# 105816
Moriguchi

A clinical research study of fluvoxamine maleate and placebo for the treatment of Obsessive Compulsive Disorder